Skip to main content

Table 3 Univariate prognostic analysis of overall survival and disease-free survival in HCC patients

From: DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1

Variable

n

Overall survival rate (%)

Disease-free survival rate (%)

3y

5y

P value

3y

5y

P value

Gender

       

 Female

25

87.7

66.8

 

56.0

44.0

 

 Male

87

60.9

46.4

0.100

47.1

31.8

0.234

Age (year)

       

  ≤ 45

29

82.4

57.3

 

62.1

37.9

 

  > 45

83

61.4

40.8

0.417

44.6

34.7

0.639

HBsAg statusa

       

 Negative

22

90.5

85.4

 

72.7

59.1

 

 Positive

90

61.1

41.4

0.008*

43.3

29.6

0.017*

Cirrhosis

       

 No

37

64.2

58.1

 

51.4

39.9

 

 Yes

75

68.0

47.7

0.440

48.0

33.3

0.457

AFP (μg/l)b

       

  ≤ 400

55

61.3

53.4

 

49.1

39.7

 

  > 400

57

71.9

48.7

0.699

49.1

31.6

0.714

Tumor size

       

  ≤ 5 cm

37

75.7

58.9

 

51.4

39.9

 

  > 5 cm

75

62.3

46.8

0.398

48.0

33.3

0.938

Tumor number

       

 Single

86

71.8

57.1

 

55.8

43.9

 

 Multiple

26

50.0

30.8

<0.001*

26.9

7.7

<0.001*

Tumor capsule

       

 Complete

20

75.0

52.2

 

50.0

44.4

 

 Incomplete

92

65.0

50.5

0.507

48.9

33.7

0.611

Vascular invasion

       

 No

86

67.2

55.0

 

53.5

41.6

 

 Yes

26

65.4

37.1

0.011*

34.6

15.4

0.004*

Edmondson grade

       

 I/II

64

76.3

56.0

 

64.1

44.8

 

 III/IV

48

54.2

43.7

0.027*

29.2

22.9

0.002*

TNM stage

       

 I/II

67

69.8

62.0

 

58.2

47.5

 

 III/IV

45

62.2

34.0

<0.001*

35.6

17.8

0.001*

DDR2 level

       

 Low

56

83.7

66.3

 

69.6

53.1

 

 High

56

50.0

35.7

<0.001*

28.6

17.9

<0.001*

  1. a HbsAg hepatitis B surface antigen, b AFP a-fetoprotein, *P < 0.05